Skip to content

Diagnostic Utility of Exercise Cardiac Magnetic Resonance in the Assessment of Cardiac Dyspnea.

Diagnostic Utility of Exercise Cardiac Magnetic Resonance in the Assessment of Cardiac Dyspnea.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03951779
Enrollment
9
Registered
2019-05-15
Start date
2018-12-14
Completion date
2020-01-10
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac; Dyspnea, Shortness of Breath

Brief summary

Researchers are examining the diagnostic utility of an exercise cardiac MRI (eCMR) in the assessment of cardiac dyspnea (shortness of breath).

Interventions

DIAGNOSTIC_TESTExercise cardiac magnetic resonance imaging

Subjects will exercise on a treadmill and immediately following the completion of the stress protocol, subjects will undergo cardiac magnetic resonance imaging

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive patients aged ≥18 years years with suspected cardiac dyspnea who are scheduled to undergo right heart catheterization as dictated by a comprehensive examination and echocardiography will be included for enrollment.

Exclusion criteria

* Age \<18 years * Pregnancy * Mechanical ventilation * Acute or chronic renal failure (creatinine clearance \<30 ml/min or requiring renal replacement therapy) * Inability to perform MRI (i.e. claustrophobia, severe obesity (\>150 kg), device incompatible with MRI) * Inability to exercise * Significant arrhythmia that precludes adequate ECG-gating for the MRI (i.e. atrial fibrillation with highly variable cycle lengths) * Prior heart or lung transplantation * Left ventricular systolic (ejection fraction \<50%) or diastolic failure (based on Framingham criteria for heart failure with preserved ejection fraction) * Significant left-sided valvular disease (≥moderate aortic stenosis, mitral stenosis, aortic regurgitation, mitral regurgitation) or prior valve surgery

Design outcomes

Primary

MeasureTime frameDescription
Ejection FractionBaselineMeasured using exercise cardiac magnetic resonance imaging (eCMR) reported in percentages
Stroke VolumeBaselineMeasured using exercise cardiac magnetic resonance imaging (eCMG) reported in mL
Longitudinal Strain AssessmentBaselineMeasured using exercise cardiac magnetic resonance imaging (eCMG) reported in percentages

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026